AU2003286868A1 - Solution for cessation of smoking and method to use - Google Patents
Solution for cessation of smoking and method to useInfo
- Publication number
- AU2003286868A1 AU2003286868A1 AU2003286868A AU2003286868A AU2003286868A1 AU 2003286868 A1 AU2003286868 A1 AU 2003286868A1 AU 2003286868 A AU2003286868 A AU 2003286868A AU 2003286868 A AU2003286868 A AU 2003286868A AU 2003286868 A1 AU2003286868 A1 AU 2003286868A1
- Authority
- AU
- Australia
- Prior art keywords
- cessation
- smoking
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000391 smoking effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66107703A | 2003-09-15 | 2003-09-15 | |
| US10/661,077 | 2003-09-15 | ||
| PCT/US2003/034971 WO2005034968A1 (fr) | 2003-09-15 | 2003-11-03 | Solution pour arreter de fumer et procede d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003286868A1 true AU2003286868A1 (en) | 2005-04-27 |
Family
ID=34435317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003286868A Abandoned AU2003286868A1 (en) | 2003-09-15 | 2003-11-03 | Solution for cessation of smoking and method to use |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003286868A1 (fr) |
| WO (1) | WO2005034968A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE521512C2 (sv) | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
| ES2708552T3 (es) | 2002-12-20 | 2019-04-10 | Niconovum Ab | Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC) |
| JP5694645B2 (ja) | 2006-03-16 | 2015-04-01 | ニコノヴァム エービーNiconovum Ab | 改善された嗅ぎたばこ組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4867181A (en) * | 1986-03-18 | 1989-09-19 | Smolko Milan S | Non-smoking aid |
| JO1560B1 (en) * | 1989-01-21 | 1991-11-27 | الشركة العربية لصناعة الأدوية المساهمة المحدودة | Mouthwash to prevent smoking |
-
2003
- 2003-11-03 WO PCT/US2003/034971 patent/WO2005034968A1/fr not_active Ceased
- 2003-11-03 AU AU2003286868A patent/AU2003286868A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005034968A1 (fr) | 2005-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL165882A0 (en) | Method of promoting smoking cessation | |
| AU2003231048A1 (en) | Transposon system and methods of use | |
| AU2003303128A1 (en) | Inhibitors and methods of use thereof | |
| GB0325192D0 (en) | Method of use | |
| AU2003217870A1 (en) | Pini-modulating compounds and methods of use thereof | |
| AU2003225668A1 (en) | Pin1-modulating compounds and methods of use thereof | |
| AU2003213673A1 (en) | Pin1-modulating compounds and methods of use thereof | |
| ZA200506790B (en) | Arylvinylazacycloalkane compounds and method of preparation and use thereof | |
| AU2003247444A1 (en) | Composition and method for cessation of nicotine cravings | |
| AU2003900769A0 (en) | Medication and smoking cessation watch | |
| IL175657A0 (en) | Derivatives of dihydronepetalactone and method for preparation | |
| AU2003286868A1 (en) | Solution for cessation of smoking and method to use | |
| PL377999A1 (pl) | Pochodne acyloaminotiazolu, sposób ich wytwarzania i ich zastosowanie jako inhibitorów syntezy peptydu ß-amyloidu | |
| AU2003229459A1 (en) | Methods of using thiazolidinedithione derivatives | |
| AU2003272390A1 (en) | AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
| GB2394223B (en) | Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation | |
| AU2003265263A1 (en) | ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
| AU2003267208A1 (en) | Method of using cigarettes | |
| AU2002950228A0 (en) | Method of aiding cessation of tobacco smoking | |
| AU2003251826A1 (en) | Mp21s as modifiers of the p21 pathway and methods of use | |
| AU2003258095A1 (en) | MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
| GB0115568D0 (en) | Method to aid smoking cessation | |
| HK1093492A (en) | Substituted pyrimdinone derivatives and methods of use | |
| PL351600A1 (en) | Method of obtaining modified fine-crystalline chitozane | |
| AU2003299990A1 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |